Recruiting
Phase 2

Alzheimer's Treatment

Sponsor:

Cyclo Therapeutics, Inc.

Code:

NCT05607615

Conditions

Alzheimer's Disease

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Hydroxypropyl Beta Cyclodextrin

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-11. This information was provided to ClinicalTrials.gov by Cyclo Therapeutics, Inc. on 2023-04-25.